Company News

FDA Approves New Prescription Ointment for Eczema

Manufactured by Anacor Pharmaceuticals.

Author Image

By: Christine Esposito

Editor-in-Chief

The US Food and Drug Administration today approved prescription-only Eucrisa (crisaborole) ointment to treat mild to moderate eczema (atopic dermatitis) in patients two years of age and older.  The ointment is made by Palo Alto, California-based Anacor Pharmaceuticals, Inc., which was acquired by Pfizer this past summer.   “Today's approval provides another treatment option for patients dealing with mild to moderate atopic dermatitis,” said Amy Egan, deputy director of the Off...

Continue reading this story and get 24/7 access to Happi for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Happi Newsletters